Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring

OBJECTIVE: CoronaVac (Sinovac) Covid-19 vaccine has recently been approved for emergency use by the World Health Organization. However, data on its reactogenicity in real-world settings is scant. This study aimed to compare self-reported post-vaccination adverse reactions between CoronaVac and Comir...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Francisco Tsz Tsun, Leung, Miriam Tim Yin, Chan, Edward Wai Wa, Huang, Lei, Lau, Lauren Ka Wun, Peng, Kuan, Leung, Janice Ching Nam, Fan, Min, Chen, Kailin, Lum, Dawn Hei, Li, Xue, Chui, Celine Sze Ling, Wan, Eric Yuk Fai, Wong, Carlos King Ho, Lam, Edwin Fung Shing, Cheung, Terence Yung Yan, Cowling, Benjamin John, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818394/
https://www.ncbi.nlm.nih.gov/pubmed/35140013
http://dx.doi.org/10.1016/j.vaccine.2022.01.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818394/
https://www.ncbi.nlm.nih.gov/pubmed/35140013
http://dx.doi.org/10.1016/j.vaccine.2022.01.062

Ejemplares similares